U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C6H6N4O2
Molecular Weight 166.1374
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of 1-METHYLXANTHINE

SMILES

CN1C(=O)NC2=C(NC=N2)C1=O

InChI

InChIKey=MVOYJPOZRLFTCP-UHFFFAOYSA-N
InChI=1S/C6H6N4O2/c1-10-5(11)3-4(8-2-7-3)9-6(10)12/h2H,1H3,(H,7,8)(H,9,12)

HIDE SMILES / InChI

Approval Year

PubMed

PubMed

TitleDatePubMed
Structure-activity relationships for the binding of ligands to xanthine or guanine phosphoribosyl-transferase from Toxoplasma gondii.
1995 Nov 9
Neurotoxic convulsions induced by theophylline and its metabolites in mice.
1996 Jun
The effect of pregnancy on cytochrome P4501A2, xanthine oxidase, and N-acetyltransferase activities in humans.
2001 Aug
Use of novel solid-phase extraction sorbent materials for high-performance liquid chromatography quantitation of caffeine metabolism products methylxanthines and methyluric acids in samples of biological origin.
2001 Aug 15
Urinary biomarkers for assessing dietary exposure to caffeine.
2001 Dec
Physiologic hyperinsulinemia enhances human skeletal muscle perfusion by capillary recruitment.
2001 Dec
Caffeine metabolism before and after liver transplantation.
2001 Feb
Determination of urinary methylated purine pattern by high-performance liquid chromatography.
2001 Feb 10
Caffeine metabolism in a group of 67 patients with primary biliary cirrhosis.
2001 Jan
Inhibition of human CYP1A2 activity in vitro by methylxanthines: potent competitive inhibition by 8-phenyltheophylline.
2001 Mar
Effects of acute renal failure induced by uranyl nitrate on the pharmacokinetics of intravenous theophylline in rats: the role of CYP2E1 induction in 1,3-dimethyluric acid formation.
2002 Dec
Skeletal muscle microvascular recruitment by physiological hyperinsulinemia precedes increases in total blood flow.
2002 Jan
T-1032, a cyclic GMP phosphodiesterase-5 inhibitor, acutely blocks physiologic insulin-mediated muscle haemodynamic effects and glucose uptake in vivo.
2003 Dec
Interaction of ibuprofen and probenecid with drug metabolizing enzyme phenotyping procedures using caffeine as the probe drug.
2003 Feb
Pharmacokinetics of intravenous theophylline in mutant Nagase analbuminemic rats.
2003 Jan 31
Inhibiting NOS blocks microvascular recruitment and blunts muscle glucose uptake in response to insulin.
2003 Jul
Preventive effect of zaprinast and 3-isobutyl, 1-methylxanthine (phosphodiesterase inhibitors) on gastric injury induced by nonsteroidal antiinflammatory drugs in rats.
2003 May
TNF-alpha acutely inhibits vascular effects of physiological but not high insulin or contraction.
2003 Sep
Cytochrome P450 1A2 (CYP1A2) activity and risk factors for breast cancer: a cross-sectional study.
2004
Cytochrome P450 1A2 (CYP1A2) activity, mammographic density, and oxidative stress: a cross-sectional study.
2004
Local methacholine but not bradykinin potentiates insulin-mediated glucose uptake in muscle in vivo by augmenting capillary recruitment.
2004 Dec
Insulin sensitivity of muscle capillary recruitment in vivo.
2004 Feb
Inhibition of the human organic anion transporter 1 by the caffeine metabolite 1-methylxanthine.
2004 Jul 16
Acetylator phenotyping in patients with malignant lymphomas, using caffeine as the metabolic probe.
2004 Jul-Aug
Phenotyping of N-acetyltransferase type 2 by caffeine from uncontrolled dietary exposure.
2004 Mar
High-throughput liquid chromatography-tandem mass spectrometry assay for plasma theophylline and its metabolites.
2004 Nov
Separation, pre-concentration, and HPLC analysis of methylxanthines in urine samples.
2004 Oct
Skeletal muscle contraction stimulates capillary recruitment and glucose uptake in insulin-resistant obese Zucker rats.
2004 Oct
Re-investigation of the concordance of human NAT2 phenotypes and genotypes.
2005 Apr
Measurement of caffeine and five of the major metabolites in urine by high-performance liquid chromatography/tandem mass spectrometry.
2005 Mar
Caffeine N3-demethylation (CYP1A2) in a population with an increased exposure to polychlorinated biphenyls.
2006 Dec
Effect of diet on the development of drug metabolism by cytochrome P-450 enzymes in healthy infants.
2006 Dec
[Determination of the activity of cytochrome P-450 CYP2A6 by HPLC method with caffeine as metabolizing probe].
2006 Mar
Reduction in non-glomerular renal clearance of the caffeine metabolite 1-methylxanthine by probenecid.
2007 Aug
In vivo evaluation of CYP1A2, CYP2A6, NAT-2 and xanthine oxidase activities in a Greek population sample by the RP-HPLC monitoring of caffeine metabolic ratios.
2007 Feb
Acute effects of wortmannin on insulin's hemodynamic and metabolic actions in vivo.
2007 Mar
Anti-inflammatory effect of theophylline in rats and its involvement of the glucocorticoid-glucocorticoid receptor system.
2008 Apr
Point: There is capillary recruitment in active skeletal muscle during exercise.
2008 Mar
Relaxing and contracting effects of theophylline's metabolites on the rabbit upper gastrointestinal tract.
2008 Oct
Enhancement of radiotherapeutic effectiveness by temperature-sensitive liposomal 1-methylxanthine.
2009 May 8
Demethylation of theophylline (1,3-dimethylxanthine) to 1-methylxanthine: the first step of an antioxidising cascade.
2010
Is 1-methylxanthine an ideal model substrate for establishing the renal tubular transport of organic ions?
2010 Feb
Plant polyphenol curcumin significantly affects CYP1A2 and CYP2A6 activity in healthy, male Chinese volunteers.
2010 Jun
Loss of insulin-mediated microvascular perfusion in skeletal muscle is associated with the development of insulin resistance.
2010 Sep
Name Type Language
1-METHYLXANTHINE
Systematic Name English
XANTHINE, 1-METHYL-
Systematic Name English
1H-PURINE-2,6-DIONE, 3,7-DIHYDRO-1-METHYL-
Systematic Name English
1H-PURINE-2,6-DIONE, 3,9-DIHYDRO-1-METHYL-
Systematic Name English
Code System Code Type Description
MESH
C053085
Created by admin on Fri Dec 15 17:48:38 GMT 2023 , Edited by admin on Fri Dec 15 17:48:38 GMT 2023
PRIMARY
FDA UNII
7EE8WCA32U
Created by admin on Fri Dec 15 17:48:38 GMT 2023 , Edited by admin on Fri Dec 15 17:48:38 GMT 2023
PRIMARY
EPA CompTox
DTXSID30210271
Created by admin on Fri Dec 15 17:48:38 GMT 2023 , Edited by admin on Fri Dec 15 17:48:38 GMT 2023
PRIMARY
PUBCHEM
80220
Created by admin on Fri Dec 15 17:48:38 GMT 2023 , Edited by admin on Fri Dec 15 17:48:38 GMT 2023
PRIMARY
CAS
6136-37-4
Created by admin on Fri Dec 15 17:48:38 GMT 2023 , Edited by admin on Fri Dec 15 17:48:38 GMT 2023
PRIMARY
ECHA (EC/EINECS)
228-108-5
Created by admin on Fri Dec 15 17:48:38 GMT 2023 , Edited by admin on Fri Dec 15 17:48:38 GMT 2023
PRIMARY